Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FRSL4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,732
Award facts
- Contract value 100% obligated
- $71,731.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $71,731.85 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This contract is a child award issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle valued through December 2026.
Entresto is a combination medication used primarily for heart failure treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply needs to support military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supplies critical medications and medical commodities to federal defense and healthcare programs through competitive procurement processes. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DB25FRSL4?
SPE2DB25FRSL4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FRSL4 worth?
The government has obligated $71,732 on SPE2DB25FRSL4.
Is contract SPE2DB25FRSL4 an order under another contract?
Yes. SPE2DB25FRSL4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRSL4 competed?
The extent of competition for SPE2DB25FRSL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award